Vivesto Stock

Vivesto EPS

The Earnings per Share (EPS) of Vivesto (VIVE.ST) as of Aug 10, 2026 is -0.21 SEK. In the previous year, Earnings per Share (EPS) was -0.65 SEK — a change of -67.73% (higher).

EPS

-0.21SEK

YoY

-67.73%

Last updated:

Earnings per Share (EPS) of Vivesto is 2026 -0.21 SEK. Earnings per Share (EPS) of Vivesto was 2025 -0.65 SEK. It decreases by -67.73% higher compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

Earnings per Share (EPS) of Vivesto is -0.21 SEK in 2026.

Earnings per Share (EPS) of Vivesto changed from -0.65 SEK to -0.21 SEK, representing a -67.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Vivesto since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

Income Statement — Vivesto

All Key Metrics — Vivesto